Biobanking Victoria

  • First NATA accredited biobank in Australia

  • 4.5 million biological specimens currently stored in the biostore

  • 50,000 biological specimens delivered to research annually

  • 6 clinical trials supported by the facility

Biobanking Victoria is the first industry-focused biobank in Australia.

Developed by the Monash University School of Clinical Sciences at Monash Health,  with the support of the Victorian State Government in collaboration with RUCDR Infinite Biologics in New Jersey.

The innovative facility operates at international standards and provides a complete end-to-end solution for biological material collection, handling, storage and analysis to support precision medicine, genomics, clinical trials, translational research and commercialisation opportunities to improve health outcomes.

The Biobanking Victoria facility offers

Dedicated laboratory flows and a laboratory information management system (LIMS)

Supporting the reception, processing and storage of a wide range of biological materials including blood, saliva, solid tissues and faecal material.

Automated laboratory instruments

Supporting blood fractionation, nucleic acid extraction, genotyping, DNA sequencing and quality control. Specialist laboratories facilitate histopathology, tissue culture and molecular analyses.

Custom-built biostore

Providing secure, 24/7 monitored storage for biological material in auto-fill, liquid nitrogen tanks and in -80°C freezers.

Specialist handling and shipping

Specialist handling and shipping of biological material including international destinations.

Collaborative opportunities

Collaborative opportunities between researchers and industry that would otherwise not be possible.

-

Watch the Biobank Victoria facility video

-

Interested to find out more about Biobanking Victoria?
Connect with our team today.

Call us on: +61 3 8572 2389

Biobanking Victoria news

National Collaboration Strengthens Rare Disease Research with New Bone Marrow Failure Biobank at Monash

A major national collaboration between Monash University and Maddie Riewoldt’s Vision has delivered a key research infrastructure milestone with the establishment of the Australian Marrow Failure Biobank (AMFB), a purpose-built biobank to accelerate research into Bone Marrow Failure Syndromes (BMFS). The first sample has now been collected, marking the start of this nationally significant resource.